Thyroid Eye Disease

ISBN-13: 9781493917457 / Angielski / Twarda / 2014 / 157 str.

Raymond Douglas; Allison B. McCoy; Shivani Gupta

Opis

This book offers ophthalmologists and medical practitioners a concise, data-driven review of the information that is most relevant in guiding the diagnosis and management of thyroid-associated eye diseases (TED). Thyroid-Associated Eye Disease can be read in its entirety to give a perspective of the field, but also considered as a reference as clinical questions arise. The goal is to deliver data- driven guidance and discreet approaches and suggestions useful for clinical practice and decision making. Advances in diagnostic evaluation, including autoantibody assessment, are reviewed, and the diagnostic features of euthyroid TED are also discussed. All relevant aspects of treatment are covered, from the use of radioactive iodine, long-term medical therapy, and surgical thyroidectomy through to the treatment of active TED by steroids and novel biologics and the role of minimally invasive surgery. Numerous supporting images are included, and helpful checklists will aid the practitioner in treatment decision making.

Recenzje

From the book reviews:

"The purpose is to help summarize and interpret the most recent studies and data related to thyroid eye disease. This book is useful for ophthalmologists, endocrinologists, general physicians, and residents. ... This is an outstanding book that helps summarize important advances in the management of patients with thyroid eye disease. It is well written and extremely useful for those managing these difficult patients." (Christopher B. Chambers, Doody's Book Reviews, March, 2015)

Spis treści

Table of Contents

 

Chapter 1        Diagnosis and Endocrine Management of Graves’ Disease

                        George J. Kahaly

Chapter 2        Natural History of Thyroid Eye Disease

                        Peter J. Dolman

Chapter 3        Emerging Role of Fibrocytes in the Pathogenesis of Thyroid Eye Disease

                        Terry J. Smith

Chapter 4        Management of Hyperthyroidism and the Effects on Thyroid Eye Disease

                        Fatemeh Rajaii, Shivani Gupta, and Raymond S. Douglas

Chapter 5        Smoking and Prevention of Thyroid Eye Disease

                        Wilmar M. Wiersinga

Chapter 6        Nutrition and Supplements in Thyroid Eye Disease

                        Claudio Marcocci and Francesca Menconi

Chapter 7        Pregnancy and Childhood Thyroid Eye Disease

                        Andrew G. Gianoukakis, Teeraun Jirajariyavej, Rebecca A. Hicks, Jennifer K.                                Yee

Chapter 8        Medical Management of Mild and Moderate to Severe Thyroid Eye Disease

                        Lucy Clarke and Petros Perros

Chapter 9        Management of Severe Thyroid Eye Disease and Use of Biological Agents

                        Mario Salvi, Richard L. Scawn, Roman Farjardo, Bobby S. Korn, Don O.                                      Kikkawa

Chapter 10      Strabismus in Thyroid Eye Disease

                        Bokkwan Jun and Prem S. Subramanian

Chapter 11      Customized Minimally Invasive Orbital Decompression for Thyroid Eye Disease

                        Shivani Gupta, Allison N. McCoy, and Raymond S. Douglas

Chapter 12      Non-Invasive, Minimally Invasive and Surgical Pearls for Cosmetic Rejuvenation              of the Thyroid Eye Disease Patient

                        Robert Goldberg and Daniel B. Rootman

Chapter 13      Psychological Disturbances in Thyroid Eye Disease

                        Sally Liu Baxter, Richard L. Scawn, Bobby S. Korn, Don O. Kikkawa

O autorze

Raymond S. Douglas, MD, PhD, studied at the University of Pennsylvania and subsequently completed his residency in ophthalmology at the Scheie Eye Institute, University of Pennsylvania and his fellowship in orbital facial plastic and reconstructive surgery at the Jules Stein Eye Institute, University of California, Los Angeles. He is currently Associate Professor of Ophthalmology and Visual Sciences and a specialist in eye plastic, orbital, and facial cosmetic Surgery at the University of Michigan, Kellogg Eye Institute. Dr. Douglas’ particular interests include orbital surgery, especially minimally invasive surgery, and decompressions for thyroid-associated eye disease; cosmetic facial surgery; and post-cancer reconstruction, including Mohs surgery.

Allison N. McCoy, MD, PhD, undertook her medical training at Duke University, Durham, North Carolina and also gained a doctorate in Neurobiology from the same university. Between 2008 and 2011 she served an Ophthalmology Residency at the Wilmer Eye Institute, Baltimore, and she is currently a Fellow in Eye Plastic, Orbital, and Facial Cosmetic Surgery. Dr. McCoy has been involved in a number of research projects and has been the recipient of the Neil Miller Research Grant Award, the Michael Boland Research Grant Award, the Mitchell Prize for Resident Research, and a Heed Fellowship. She is the author of 15 peer-reviewed publications.

Shivani Gupta, MD, MPH is an Eye Plastic, Orbital and Facial Cosmetic Surgery Lecturer in the Department of Ophthalmology and Visual Sciences at the University of Michigan. Her special interests include orbital surgery, cosmetic facial surgery including fillers and Botox injections, eyelid and lacrimal disorders, post-cancer reconstruction including Mohs' surgery.

Blurb

This book offers ophthalmologists and medical practitioners a concise, data-driven review of the information that is most relevant in guiding the diagnosis and management of thyroid eye disease (TED). Particular attention is devoted to research and clinical trials that have advanced the field in recent years.

Progress in our understanding of the pathogenesis of TED is described, and the heterogeneous natural history of TED is discussed to facilitate preemptive interventions. Advances in diagnostic evaluation, including autoantibody assessment, are reviewed with regard to their clinical utility. The diagnostic features of euthyroid TED are also carefully covered since these patients often represent a diagnostic dilemma.

All relevant aspects of treatment are addressed including the role of radioactive iodine, long-term medical therapy, and surgical thyroidectomy. The impact of these treatment modalities on eye disease are discussed. Management of active TED is reviewed according to the severity of disease and in the light of recent findings and the introduction of novel agents. The discussion encompasses the role of steroids and other agents, the use of novel biologics, the medical and surgical treatment of optic neuropathy, and minimally invasive, customized reconstructive surgery. Numerous supporting images are included, and helpful checklists will aid the practitioner in treatment decision making.